Lab Genomics will export 5.8 billion won ($4.8 million) worth of LabGun COVID-19 ExoFast RT-PCR Kit to India through Siemens Healthineers’s India branch.
|Lab Genomics will export 5.8 billion won worth of its Covid-19 diagnostic kit to India. (Lab Genomics)|
The deal accounts for 17.56 percent of the company's total sales last year, it said.
Under this accord, Lab Genomics will supply its LabGun COVID-19 ExoFast RT-PCR Kit, which can diagnose the new coronavirus within an hour of testing using real-time polymerase chain reaction method.
Lab Genomics obtained the U.S. Food and Drug Administration's Emergency Use Authorization (EUA) for the kit in April and won Europe’s Conformite Europeenne Mark-In Vitro Diagnostic (CE-IVD) certification later. The Ministry of Food and Drug Safety also granted EUA approval to the kit on June 24.